Breast Cancer Treatment Studied
Posted on: Friday, 12 May 2006, 12:02 CDT
A recent U.S. medical study says chemotherapy to treat breast cancer might be recommended for only 30 percent of women whose cancer is not fueled by estrogen.
After years of adding more drugs, shorter intervals between chemotherapy sessions, higher doses and longer periods of harsh therapy, doctors are wondering whether many women could skip chemotherapy altogether, the New York Times reported Friday.
Among the less convinced is Dr. John H. Glick, director of the Abramson Cancer Center of the University of Pennsylvania. He tells his patients about the new data, but does not suggest they skip chemotherapy. Glick notes the national guidelines were based on results from large randomized clinical trials.
It could be a decade before the new studies in the United States and Europe provide any answers, the report said.
Chemotherapy saves lives and newer and more aggressive regimens are improvements over older ones. So many doctors feel more at ease giving very aggressive cancer-fighting treatments to almost every patient.
Still, doctors say it is not simply that they are urging more and more chemotherapy on patients. In many cases, it is patients who want the most aggressive treatment, the Times said.
Source: United Press International
Related Articles
- Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies
- As Health Goes Awry, Doctor-Patient Relationship Grows
- Prostate Cancer - Hormone-Refractory Patients Still Waiting for Treatment Breakthroughs
- Geron Initiates Clinical Trial of Telomerase Cancer Vaccine in Patients With Acute Myelogenous Leukemia
- Cell Genesys Reports GVAX Immunotherapy for Prostate Cancer Induces a Broad, Patient-Specific Antibody Response
- Majority of Cancer-Related Anemia Patients Treated With PROCRIT(R) (Epoetin Alfa) Once Every Three Weeks Achieved Target Hemoglobin
- MIMA Cancer Center Offers Patients Most Advanced Image Guided Radiation Therapy (IGRT) From BrainLAB
- Goal of IBM Project: Let Doctors, Patients, Hospitals Share E-Data
- Interim Analysis of Phase III Trial Shows Avastin Plus Chemotherapy Extends Survival of Patients With First-Line Non-Squamous, Non-Small Cell Lung Cancer
- Vitamin E Scare Hurts Cancer Trial; Doctors Say Their Study on Supplement, Prostate Cancer Prevention is Safe
 |
 |
User Comments (0)
RSS Feeds